Medical Letter on the CDC and FDA

Clinical Trial Research - Replidyne Discontinues Phase III Trial

Coagulation - Ortho Evra Patch Makers Settling Cases

Colon Cancer - Sirtex Supports the Fourth Annual Clinical Symposium on Liver-Directed Microsphere Therapy Dedicated to Advancing Treatments for Patients with Inoperable Metastatic Liver Cancer

Cord Blood - Pregnant Women Need Omega-3 to Boost Infant Development

Crohn Disease - FDA Approval of Cimzia(R) for Crohn's Disease Represents Latest Milestone for Nektar's PEGylation Technology Platform

Crohn Disease - UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers

Depression - St. Jude Medical Awarded U.S. Patent for Neurostimulation Therapy for Depression

Diabetes - Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema

Diabetes - VitalCare Announces FDA Approval of Infusion Device Used for iCAT Therapy

DRJ Group, Inc. - Stopain(R) Topical Pain Reliever Enhances Products, Packaging and Distribution

Drug Abuse - King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III Clinical Trial Evaluating ACUROX(TM)

Drug Development - Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder

Drug Resistance - Targanta Announces Highlights of Oritavancin Data to Be Presented at the 18th ECCMID

Endometrial Ablation - Endometrial Ablation Shown Effective for Heavy Periods, Says Miami OB-GYN Specialist

Fibroids - InSightec to Exhibit Non-Invasive Treatment for Uterine Fibroids at 5th Annual World Health Care Congress

General Physics Corporation (GP) - General Physics Corporation Launches ''GPiLearn Rx'', a New Life Science Compliance Online Training Solution

Heart Attack - Amkor Pharma, Inc. Completes All Clinical Activities for Its Phase I Study of Neu2000KL for Treatment of Acute Brain Injury

ImaRx Therapeutics, Inc. - ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase

Immunization - The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)

InfuScience Inc. - InfuScience Procures Vivaglobin(R) for in-Home Infusion Therapy

Kidney Disease - Genzyme Reports Strong First-Quarter Growth

Marketing and Licensing Agreements - SCHOTT Forms Pharmaceutical Joint Venture in India

Massachusetts Institute of Technology - MIT-led teams unravel heparin death mystery

Medical Device Manufacturers Association - Key Industry and Government Officials to Address Medical Technology Executives

Melanoma - BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO

Mental Health - FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults

Merck & Co., Inc. - Two Merck Medicines Recommended for Approval in the European Union

Non-Small Cell Lung Cancer - Genentech Provides Update on ''AVAiL'' Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer

Obesity - U.S. Surgeon General Launches New Effort to Address Childhood Obesity

Oculus Innovative Sciences, Inc. - Oculus Innovative Sciences Appoints Michelle Carpenter, JD, RAC, as Vice President of Regulatory Affairs and Quality

Osteoporosis - FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis

Peripheral T-Cell Lymphoma - Allos Therapeutics Completes Patient Enrollment in Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma

PPD, Inc. - PPD Reports First Quarter 2008 Financial Results

QLT Inc. - QLT announces first quarter results for 2008

Regulatory Actions - Health Canada Draft Assessment Supports Safety of Bisphenol A

Regulatory Actions - Nigeria Pharmaceutical Market Should Grow at around 5% Year-on-Year Reaching Us$369Mn by 2012

Retinal Disease - Sirion Therapeutics Preclinical Studies: Two New Potential Advances in Treatment of Retinal Diseases to be Presented at ARVO

Schizophrenia - ARYx Therapeutics Enters Clinic with Novel Antipsychotic Drug for Patients with Schizophrenia

Taro Pharmaceutical Industries Ltd. - Taro Receives Final FDA Approval for Cetirizine Hydrochloride Oral Solution ANDA

Tissue Engineering - Starion Instruments Receives Chinese Regulatory Approval

Tissue Engineering - Synovis Life Technologies to Broadcast a Component Separation Procedure Using Veritas(R) Collagen Matrix April 30 on ORLive(TM)

Transfusion Medicine - Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial

Transplantation - Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation

Wyeth Pharmaceuticals - More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL

Yulex Corporation - FDA Clears First Medical Product Made From Yulex(R) Natural Rubber

Zila, Inc. - Zila Receives FDA 510(k) Clearance for ViziLite Eyewear